title: Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story?
authors.forename: Stefano
authors.initials: S
authors.lastname: Taddei
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Ghiadoni
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000187:drug effects*; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*
chemical_list: D010726:Phosphodiesterase Inhibitors; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human